Madrid

Madrid 28046

1 studies enrolling now · 13 studies all time

What they study most

Cirrhosis, Cutaneous T-cell Lymphoma (CTCL),, Endometriosis, Endometriosis Related Pain, Heart Failure With Preserved Ejection Fraction, Hepatitis C, Hypertension, Pulmonary, Lung Diseases, Interstitial, Non-alcoholic Steatohepatitis, Parkinson Disease, Portal Hypertension, Prostate Cancer

Studies at this site

• Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease — Recruiting now
• A Study of TX000045 in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (the APEX Study) — Running, not enrolling
• Open-label Trial in Parkinson's Disease (PD) — Completed
• An Open-label Extension Trial of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures — Stopped early
• Fixed-Dose Trial in Early Parkinson's Disease (PD) — Completed
• A Trial of the Efficacy and Safety of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures — Completed
• Flexible-Dose, Adjunctive Therapy Trial in Adults With Parkinson's Disease With Motor Fluctuations (TEMPO-3) — Completed
• SPIRIT EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Endometriosis-Associated Pain — Completed
• Emricasan, an Oral Caspase Inhibitor, in Subjects With NASH Cirrhosis and Severe Portal Hypertension — Completed
• A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer — Completed
• SPIRIT 1: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated Pain — Completed
• A Study to Treat Subjects With Telaprevir, Ribavirin, and Peginterferon Who Are Coinfected With HIV and Hepatitis C Virus (HCV) — Stopped early
• Forodesine in the Treatment of Cutaneous T-Cell Lymphoma — Completed